122. Is life science adopting AI?

AI is moving fast — but is life science actually adopting it?

In this episode of Discovery Matters, we explore how artificial intelligence is being used across pharma and life sciences, and where progress is still cautious. Joined by Joe Luminiello, CEO of RCG Intel, we discuss the balance between speed and safety, innovation and regulation, and why human context still matters as much as algorithms.

Cutting through the hype, this conversation asks not just whether the industry should use AI — but how to do it thoughtfully.